Biolegend, 300420, PE/Cyanine7 anti-human CD3 Antibody, 100tests

CD3ε is a 20 kD chain of the CD3/T-cell receptor (TCR) complex which is composed of two CD3ε, one CD3γ, one CD3δ, one CD3ζ (CD247), and a T-cell receptor (α/β or γ/δ) heterodimer. It is found on all mature T cells, NKT cells, and some thymocytes. CD3, also known as T3, is a member of the immunoglobulin superfamily that plays a role in antigen recognition, signal transduction, and T cell activation.
100tests
Verified Reactivity: Human
Reported Reactivity: Chimpanzee
Antibody Type: Monoclonal
Host Species: Mouse
Formulation: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
Preparation: The antibody was purified by affinity chromatography, and conjugated with PE/Cyanine7 under optimal conditions.
Concentration: Lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.)
Storage & Handling: The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application: FC - Quality tested
Recommended Usage: Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 µl per million cells in 100 µl staining volume or 5 µl per 100 µl of whole blood.
Excitation Laser: Blue Laser (488 nm)Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes: Additional reported applications (for the relevant formats) include: immunohistochemical staining of acetone-fixed frozen sections4,6,7 and formalin-fixed paraffin-embedded sections11, immunoprecipitation1, activation of T cells2,3,5, Western blotting9, and spatial biology (IBEX)16,17. The LEAF™ purified antibody (Endotoxin < 0.1 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 300413, 300414, and 300432). For highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Cat. No. 300437, 300438, 300465, 300466, 300473, 300474) with a lower endotoxin limit than standard LEAF™ purified antibodies (Endotoxin < 0.01 EU/µg).
Application References(PubMed link indicates BioLegend citation): Salmeron A, et al. 1991. J. Immunol. 147:3047. (IP) Graves J, et al. 1991. J. Immunol. 146:2102. (Activ) Lafont V, et al. 2000. J. Biol. Chem. 275:19282. (Activ) Ryschich E, et al. 2003. Tissue Antigens 62:48. (IHC) Thompson AG, et al. 2004. J. Immunol. 173:1671. (Activ) Sakkas LI, et al. 1998. Clin. Diagn. Lab. Immun. 5:430. (IHC) Mack CL, et al. 2004. Pediatr. Res. 56:79. (IHC) Thakral D, et al. 2008. J. Immunol. 180:7431. (FC) PubMed Van Dongen JJM, et al. 1988. Blood 71:603. (WB) Yoshino N, et al. 2000. Exp. Anim. (Tokyo) 49:97. (FC) Pollard, K. et al. 1987. J. Histochem. Cytochem. 35:1329. (IHC) Luckashenak N, et al. 2013. J. Immunol. 190:27. PubMed Laurent AJ, et al. 2014. PLoS One. 9:103683. PubMed Li J, et al. 2015. Cancer Res. 75:508. PubMed Stoeckius M, et al. 2017. Nat. Methods. 14:865-868. (PG) Radtke AJ, et al. 2020. Proc Natl Acad Sci USA. 117:33455-33465. (SB) PubMed Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations: Howson LJ, et al. 2018. Nat Commun. 9:253. PubMed Zhang C, et al. 2023. Front Immunol. 14:1182409. PubMed Shaw DG, et al. 2023. Nat Med. 29:1520. PubMed Hu Z, et al. 2022. Nat Metab. 4:759. PubMed Vazquez-Lombardi R, et al. 2022. Immunity. 55:1953. PubMed Balta E, et al. 2023. Front Immunol. 13:1063313. PubMed Andreano E, et al. 2023. Nat Commun. 14:53. PubMed Miller RA, et al. 2022. J Immunother Cancer. 10: . PubMed Iio K, et al. 2023. Immun Ageing. 20:8. PubMed Dong W, et al. 2023. Int J Mol Med. 51: . PubMed Blommaert E, et al. 2022. Hum Genet. 141:1279. PubMed Petit N, et al. 2015. PLoS One. 10: 0138420. PubMed Mayassi T, et al. 2019. Cell. 176:967. PubMed Jiang L, et al. 2021. Int J Biol Sci. 17:4377. PubMed Nagafuchi Y, et al. 2016. Sci Rep. 6:29338. PubMed Lamichhane R, et al. 2020. Eur J Immunol. 50:178. PubMed Vinjamur DS, et al. 2021. Nat Genet. 53:719. PubMed Manser AR, et al. 2019. J Immunol. 203:2301. PubMed Mashiko S, et al. 2015. J Allergy Clin Immunol. 136: 351-359. PubMed Goel G, et al. 2019. Sci Adv. 5:eaaw7756. PubMed Di Blasi D, et al. 2019. Cell Mol Gastroenterol Hepatol. 0.510416667. PubMed Weisberg SP, et al. 2020. Cell Reports. 29(12):3916-3932.e5.. PubMed Vijayakumar B, et al. 2022. Immunity. . PubMed Todorova D, et al. 2020. EBioMedicine. 62:103120. PubMed Sandborn WJ, et al. 2021. Gastroenterology. 161:1853. PubMed Ridley ML, et al. 2020. J Immunol. 204:2940. PubMed Shevyrev D, et al. 2021. Exp Ther Med. 209:21. PubMed Seumois G, et al. 2016. J Immunol. 197: 655 - 664. PubMed Leone D, et al. 2016. PLoS One. 11: 0151674. PubMed Palazzo A, et al. 2018. J Immunol. 200:2304. PubMed Taraldsrud E, et al. 2017. Journal of Autoimmunity. 10.1016/j.jaut.2017.04.004. PubMed Warmuth S, et al. 2022. Oncoimmunology. 10:2004661. PubMed , et al. 2021. Eur J Immunol. 51:2708. PubMed Ramirez NP, et al. 2022. Nat Commun. 13:1109. PubMed Usero L, et al. 2016. Diabetes. 65: 2356 - 2366. PubMed Meraviglia S, et al. 2017. Oncoimmunology. 6:e1347742. PubMed Zeng J, et al. 2020. Nat Med. 26:535. PubMed Cartellieri M, et al. 2014. PLoS One. 9:93745. PubMed Suan D et al. 2017. Immunity. 47(6):1142-1153 . PubMed Chruewkamlow N, et al. 2021. Stem Cell Res Ther. 12:520. PubMed Bonte S, et al. 2021. Oncoimmunology. 10:1954800. PubMed Alonso R, et al. 2022. Blood Adv. :. PubMed Vela M, et al. 2019. Sci Rep. 9:18792. PubMed Verma K, et al. 2017. PLoS One.. 10.1371/journal.pone.0183828. PubMed Ickrath P, et al. 2019. Biomed Rep. 10:119. PubMed Pollack RA, et al. 2017. Cell Host Microbe. 1.218055556. PubMed Moore N, et al. 2019. Sci Rep. 9:15101. PubMed Comte D, et al. 2016. Proc Natl Acad Sci U S A. 113: 9321 - 9326. PubMed Rosskopf S, et al. 2018. Oncotarget. 9:17608. PubMed Leone DA, et al. 2017. J Immunol. 199:531. PubMed Andreano E, et al. 2021. Nature. Online ahead of print. PubMed Cartellieri M, et al. 2016. Blood Cancer J. 6:e458. PubMed Iio K, et al. 2019. Sci Rep. 9:813. PubMed Román-Rodriguez FJ, et al. 2019. Cell Stem Cell. 25:607. PubMed Zhao Y, et al. 2020. Front Immunol. 2.572222222. PubMed Ishigaki K, et al. 2015. Sci Rep. 5: 12937. PubMed Beyer AI, et al. 2017. Stem Cells Dev. 26:102. PubMed Teng F, et al. 2021. Cell Rep. 37:110051. PubMed Gustafson CE, et al. 2020. JCI Insight. 5:. PubMed Gladkikh A, et al. 2017. Cancer Med. . 10.1002/cam4.1257. PubMed Ickrath P, et al. 2018. Int J Mol Med. 42:1116. PubMed Lo Presti E, et al. 2020. J Leukoc Biol. 108:749. PubMed Cruz-Lorenzo E, et al. 2022. Viruses. 14:. PubMed Andreano E, et al. 2021. Cell. 184(7):1821-1835.e16. PubMed Leylek R, et al. 2020. Cell Rep. 32:108180. PubMed Lamichhane R et al. 2019. Cell Rep. 28(12):3061-3076 . PubMed Brunk F, et al. 2021. Eur J Immunol. 51:2651. PubMed
RRID: AB_439780 (BioLegend Cat. No. 300419) AB_439781 (BioLegend Cat. No. 300420)
Structure: Ig superfamily, with the subunits of CD3γ, CD3δ, CD3ζ (CD247) and TCR (α/β or γ/δ) forms CD3/TCR complex, 20 kD
Distribution: Mature T and NK T cells, thymocyte differentiation
Function: Antigen recognition, signal transduction, T cell activation
Ligand/Receptor: Peptide antigen bound to MHC
Cell Type: NKT cells, T cells, Thymocytes, Tregs
Biology Area: Immunology, Innate Immunity
Molecular Family: CD Molecules, TCRs
Antigen References: 1. Barclay N, et al. 1993. The Leucocyte FactsBook. Academic Press. San Diego. 2. Beverly P, et al. 1981. Eur. J. Immunol. 11:329. 3. Lanier L, et al. 1986. J. Immunol. 137:2501-2507.
Gene ID: 916
UniProt: View information about CD3 on UniProt.org
Clone: UCHT1
Regulatory Status: RUO
Workshop: III 471
Other Names: T3, CD3ε
Isotype: Mouse IgG1, κ